Retinal Neurodegeneration: Correlation between Nutraceutical Treatment and Animal Model
Ilaria Piano1, Mattia Di Paolo1,2, Francesca Corsi1,3
1Department of Pharmacy, University of Pisa, Via Bonanno, 6, 56121 Pisa, Italy.
Abstract:
Retinal diseases can be induced by a variety of factors, including gene mutations, environmental stresses and dysmetabolic processes. The result is a progressive deterioration of visual function, which sometimes leads to blindness. Many treatments are under investigation, though results are still mostly unsatisfactory and restricted to specific pathologies, particularly in the case of gene therapy. The majority of treatments have been tested in animal models, but very few have progressed to human clinical trials. A relevant approach is to study the relation between the type of treatments and the degenerative characteristics of the animal model to better understand the effectiveness of each therapy. Here we compare the results obtained from different animal models treated with natural compounds (saffron and naringenin) to anticipate the potentiality of a single treatment in different pathologies.
Insights
Natural compounds like saffron and naringenin show promise for treating various retinal diseases. Comparing animal models helps predict their effectiveness across different pathologies, offering hope for vision restoration.
Area of Science:
- Ophthalmology
- Pharmacology
- Genetics
Background:
- Retinal diseases stem from genetic, environmental, and metabolic factors, causing progressive vision loss and blindness.
- Current treatments are often unsatisfactory, limited in scope, and rarely progress from animal models to human trials.
- Understanding the link between animal models and treatment efficacy is crucial for developing effective therapies.
Purpose of the Study:
- To compare the effectiveness of natural compounds (saffron, naringenin) in different animal models of retinal disease.
- To evaluate the potential of single treatments for diverse retinal pathologies.
- To bridge the gap between preclinical findings and potential clinical applications.
Main Methods:
- Utilizing various animal models representing different retinal degenerative characteristics.
- Administering natural compounds, specifically saffron and naringenin, to treated groups.
- Analyzing and comparing treatment outcomes across different models and pathologies.
Main Results:
- Saffron and naringenin demonstrated varied effects depending on the specific animal model and induced retinal pathology.
- Certain natural compounds showed potential in mitigating degenerative processes across different models.
- The study identified specific relationships between compound administration, model characteristics, and observed therapeutic outcomes.
Conclusions:
- Natural compounds like saffron and naringenin hold therapeutic potential for a range of retinal diseases.
- The choice of animal model is critical for accurately assessing the broad applicability of potential treatments.
- This comparative approach aids in predicting the efficacy of natural compounds for diverse human retinal pathologies.
